Health Care

Novartis acquires Amblyotech, pursuing novel digital therapy for children and adult patients with ‘lazy eye’

East Hanover-based Novartis announced Monday that it completed the acquisition of Amblyotech, a U.S.-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia. Designed to enhance compliance, Amblyotech utilizes active gaming and passive video technology with 3-D glasses, training the ...

Read More »